These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19034754)

  • 21. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.
    Potvin S; Stip E; Lipp O; Elie R; Mancini-Marië A; Demers MF; Roy MA; Bouchard RH; Gendron A
    Curr Med Res Opin; 2006 Jul; 22(7):1277-85. PubMed ID: 16834826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Open assessment of the safety and efficacy of thioridazine in the treatment of patients with borderline personality disorder.
    Teicher MH; Glod CA; Aaronson ST; Gunter PA; Schatzberg AF; Cole JO
    Psychopharmacol Bull; 1989; 25(4):535-49. PubMed ID: 2631134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects.
    Datto C; Berggren L; Patel JB; Eriksson H
    Clin Ther; 2009 Mar; 31(3):492-502. PubMed ID: 19393840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use.
    Philip NS; Mello K; Carpenter LL; Tyrka AR; Price LH
    Ann Clin Psychiatry; 2008; 20(1):15-20. PubMed ID: 18297582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia.
    Schulz SC; Camlin KL; Berry SA; Jesberger JA
    Biol Psychiatry; 1999 Nov; 46(10):1429-35. PubMed ID: 10578457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aripiprazole pharmacotherapy of borderline personality disorder.
    Mobascher A; Mobascher J; Schlemper V; Winterer G; Malevani J
    Pharmacopsychiatry; 2006 May; 39(3):111-2. PubMed ID: 16721700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quetiapine in anorexia nervosa patients: an open label outpatient pilot study.
    Powers PS; Bannon Y; Eubanks R; McCormick T
    Int J Eat Disord; 2007 Jan; 40(1):21-6. PubMed ID: 16927383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness, safety, and pharmacokinetics of quetiapine in aggressive children with conduct disorder.
    Findling RL; Reed MD; O'Riordan MA; Demeter CA; Stansbrey RJ; McNamara NK
    J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):792-800. PubMed ID: 16832315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The successful pharmacological treatment of adolescents and young adults with borderline personality disorder: a preliminary open trial of flupenthixol.
    Kutcher S; Papatheodorou G; Reiter S; Gardner D
    J Psychiatry Neurosci; 1995 Mar; 20(2):113-8. PubMed ID: 7703220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics.
    Martinotti G; Andreoli S; Di Nicola M; Di Giannantonio M; Sarchiapone M; Janiri L
    Hum Psychopharmacol; 2008 Jul; 23(5):417-24. PubMed ID: 18425995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quetiapine-associated cardiomyopathy.
    Coffey S; Williams M
    N Z Med J; 2011 Jun; 124(1337):105-7. PubMed ID: 21946883
    [No Abstract]   [Full Text] [Related]  

  • 32. An open-label study of quetiapine for delirium.
    Maneeton B; Maneeton N; Srisurapanont M
    J Med Assoc Thai; 2007 Oct; 90(10):2158-63. PubMed ID: 18041437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-acting injectable risperidone in treatment resistant borderline personality disorder. A small series report].
    Díaz-Marsá M; Galian M; Montes A; Fernández R; Arza R; López-Ibor J; Carrasco J
    Actas Esp Psiquiatr; 2008; 36(2):70-4. PubMed ID: 18365787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjunctive antidepressant treatment with quetiapine in agitated depression: positive effects on symptom reduction, psychopathology and remission rates.
    Dannlowski U; Baune BT; Böckermann I; Domschke K; Evers S; Arolt V; Hetzel G; Rothermundt M
    Hum Psychopharmacol; 2008 Oct; 23(7):587-93. PubMed ID: 18663773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 26-week open-label study of quetiapine in children with conduct disorder.
    Findling RL; Reed MD; O'Riordan MA; Demeter CA; Stansbrey RJ; McNamara NK
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):1-9. PubMed ID: 17343549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: a pilot study.
    Friedel RO; Jackson WT; Huston CS; May RS; Kirby NL; Stoves A
    J Clin Psychopharmacol; 2008 Jun; 28(3):345-7. PubMed ID: 18480695
    [No Abstract]   [Full Text] [Related]  

  • 37. Dose-dependent constipation with higher doses of quetiapine: a case series.
    Raedler TJ; Reimer J; Wiedemann K
    Int Clin Psychopharmacol; 2007 Jul; 22(4):244-6. PubMed ID: 17519649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An open-label study of quetiapine in anorexia nervosa.
    Bosanac P; Kurlender S; Norman T; Hallam K; Wesnes K; Manktelow T; Burrows G
    Hum Psychopharmacol; 2007 Jun; 22(4):223-30. PubMed ID: 17487935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
    DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM
    Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
    Pandina GJ; Revicki DA; Kleinman L; Turkoz I; Wu JH; Kujawa MJ; Mahmoud R; Gharabawi GM
    J Affect Disord; 2009 Nov; 118(1-3):139-46. PubMed ID: 19321206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.